Article: Novel HIV viremia model may aid evaluation of drug efficacy.

2004 JAN 16 - (NewsRx.com & NewsRx.net) -- A novel model of HIV viremia may aid evaluation of antiretroviral drug efficacy.

Scientists in the United States developed "a model of HIV dynamics under antiretroviral therapy that combines drug pharmacokinetics and intracellular delay."

"A two compartment pharmacokinetic model is employed to determine the time evolution of the intracellular concentrations of the active forms of drugs, and thereby drug efficacy," explained N.M. Dixit and coauthors working at Los Alamos National Laboratory.

"The viral replication period is divided into pre- and post-drug action parts, allowing for the introduction of an ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!